| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.70M | 14.10M | 12.00M | 10.30M | 8.40M |
| Gross Profit | 8.30M | 8.30M | 8.00M | 5.00M | 2.70M |
| EBITDA | -100.00K | -2.90M | -3.60M | -7.00M | -5.60M |
| Net Income | -2.80M | -3.60M | -4.50M | -12.30M | -6.80M |
Balance Sheet | |||||
| Total Assets | 16.40M | 19.90M | 23.10M | 27.40M | 37.30M |
| Cash, Cash Equivalents and Short-Term Investments | 3.00M | 5.10M | 9.00M | 15.60M | 24.20M |
| Total Debt | 300.00K | 600.00K | 500.00K | 600.00K | 700.00K |
| Total Liabilities | 8.00M | 8.80M | 8.50M | 8.50M | 6.30M |
| Stockholders Equity | 8.40M | 11.10M | 14.60M | 18.90M | 31.00M |
Cash Flow | |||||
| Free Cash Flow | -100.00K | -1.30M | -6.80M | -6.70M | -5.70M |
| Operating Cash Flow | -100.00K | -1.10M | -4.70M | -6.30M | -4.90M |
| Investing Cash Flow | -1.80M | -2.60M | -1.60M | -2.00M | -2.30M |
| Financing Cash Flow | -200.00K | -200.00K | -300.00K | -300.00K | 19.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £103.01M | 152.71 | 0.31% | ― | 0.97% | -71.58% | |
68 Neutral | £197.89M | 37.63 | 5.22% | 0.80% | 22.80% | -32.13% | |
68 Neutral | £139.33M | -33.80 | -2.11% | ― | 31.86% | -115.22% | |
63 Neutral | £74.21M | 23.49 | -1.09% | 2.00% | 9.69% | -319.35% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £27.54M | -7.14 | -29.25% | ― | 10.00% | 34.02% | |
46 Neutral | £36.75M | -28.61 | 49.22% | ― | 1.73% | -68.87% |